Clinical and course indicators of bipolar disorder type I with and without opioid dependence

Journal of Research in Medical Sciences

Volumn 15, Issue 1, 2010, Pages 20-26

  Shabani, Amir ^a   Jolfaei, Atefeh Ghanbari ^a   Vazmalaei, Hajar Ahmadi ^a   Ebrahimi, Azizeh Afkham ^b   Naserbakht, Morteza ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bipolar disorder; Opioid; Outcome; Substance abuse; Substance dependence

Indexed keywords

OPIATE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; CHI SQUARE TEST; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; FAMILY HISTORY; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL HOSPITAL; PSYCHOLOGIC ASSESSMENT; SAMPLE SIZE; SEX DIFFERENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; STUDENT T TEST; SUBSTANCE ABUSE;

EID: 75649143690     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baldassano CF. Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder. J Clin Psychiatry 2006;67(Suppl 11):8-11.
2. Maremmani I, Perugi G, Pacini M, Akiskal HS. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disord 2006;93(1-3):1-12.
3. Cerullo MA, Strakowski SM. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2007;2:29.
4. Arabgol F, Alaghband Rad J, Sharifi V, Hakim Shoushtari M, Shaabani A, Davari Ashtiani R, et al. Reliability of a Persian translation of the Composite International Diagnostic Interview (CIDI), section for substance use disorders: in a multi-center study in Iran. Advances in Cognitive Science 2005;7(2):38-45. (Persian)
5. Levin FR, Hennessy G. Bipolar disorder and substance abuse. Biol Psychiatry 2004;56(10):738-48.
6. Cheng AT, Chen TH, Chen CC, Jenkins R. Psychological and psychiatric risk factors for suicide. Case-control psychological autopsy study. Br J Psychiatry 2000;177:360-5.
7. Tondo L, Baldessarini RJ, Hennen J, Minnai GP, Salis P, Scamonatti L, et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry 1999;60(Suppl 2):63-9, discussion 75-6, 113-6.
8. Mazza M, Mandelli L, Di Nicola M, Hamic D, Catalano V, Tedeschi D, et al. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord 2009;115(1-2):27-35.
9. Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2000;2(3 Pt 2):269-80.
10. Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998;155(5):646-52.
11. Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005;7(2):187-91.
12. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264(19):2511-8.
13. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord 2003;5(1):58-61.
14. Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med 2002;5(3):184-90.
15. Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. A Persian translation of the Structured Diagnostic Interview for DSM-IV (SCID): psychometric properties. Compr Psychiatry 2009;50(1):86-91.
16. McIntyre R, Kennedy S, Bagby RM, Bakish D. Assessing full remission. J Psychiatry Neurosci 2002;27(4):235-9.
17. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35.
18. Barekatain M, Tavakoli M, Molavi H, Maroufi M, Salehi M. Standardization, reliability and validity of the Young Mania Rating Scale. Psychology 2007;11(2):150-66. (Persian)
19. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatry 1976;33(9):1062-6.
20. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986;255(22):3138-42.
21. Cardoso BM, Kauer Sant'Anna M, Dias VV, Andreazza AC, Ceresér KM, Kapczinski F. The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol 2008;42(6):451-7.
22. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994;182(6):349-52.
23. st ed. Melbourne: Spectrum Pubns; 1987. p. 389-96.
24. Shabani A. Strategies for decreasing false negative and positive diagnoses of bipolar disorders. Iranian Journal of Psychiatry and Clinical Psychology 2009;15(2(57)):99-127.
25. Shabani, A, Zolfigol F, Akbari M. Brief major depressive episode as an essential predictor of the Bipolar Spectrum Disorder. J Res Med Sci 2009;14(1):29-35.
26. Benazzi F, Akiskal HS. How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity? J Affect Disord 2008;107(1-3):77-88.
27. Ghaemi SN, Ko JY, Goodwin FK. "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002;47(2):125-34.
28. Winokur G, Cook B, Liskow B, Fowler R. Alcoholism in manic depressive (bipolar) patients. J Stud Alcohol 1993;54(5):574-6.
29. Simon NM, Smoller JW, Fava M, Sachs G, Racette SR, Perlis R, et al. Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res 2003;37(3):187-92.
30. Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004;65(8):1106-13.
31. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996;66(1):17-31.
32. Skinstad AH, Swain A. Comorbidity in a clinical sample of substance abusers. Am J Drug Alcohol Abuse 2001;27(1):45-64.
33. Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD. Anxiety disorders among patients with co-occurring bipolar and substance use disorders. Drug Alcohol Depend 2005;80(2):251-7.
34. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 1999;11:733-40.
35. Weiss RD. Treating patients with bipolar disorder and substance dependence: lessons learned. J Subst Abuse Treat 2004;27(4):307-12.
36. Strakowski SM, DelBello MP. The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev 2000;20(2):191-206.